N7 generics are now over 14,000 Trx … scripts that should have gone to AMRN . Plot a chart …brand V vs generic V over the last6 mths . There may be formulary changes … lower tiers etc … but what benefit there is , is mainly going to the generics Maybe you or Captbeer can post graphs … brand vs generics past 6 mths
Thx to RAF for the script numbers
There’s probably going to be an MBA class sometime on what can go wrong in a biotech Co AMRN would be a great example Kiwi